GOSS
Income statement / Annual
Last year (2024), Gossamer Bio, Inc.'s total revenue was $114.70 M,
and the percentage change from the previous year is not available.
In 2024, Gossamer Bio, Inc.'s net income was -$56.53 M.
See Gossamer Bio, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
| Operating Revenue |
$114.70 M |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Cost of Revenue |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$4.27 M
|
$3.09 M
|
$297.00 K
|
$0.00
|
$0.00
|
| Gross Profit |
$114.70 M
|
$0.00
|
$0.00
|
$0.00
|
-$4.27 M
|
-$3.09 M
|
-$297.00 K
|
$0.00
|
$0.00
|
| Gross Profit Ratio |
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Research and Development Expenses |
$138.49 M
|
$135.30 M
|
$170.92 M
|
$170.27 M
|
$158.00 M
|
$143.40 M
|
$55.28 M
|
$891.00 K
|
$0.00
|
| General & Administrative Expenses |
$36.13 M
|
$38.46 M
|
$47.61 M
|
$45.78 M
|
$0.00
|
$39.14 M
|
$44.05 M
|
$262.00 K
|
$83.00 K
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$36.13 M
|
$38.46 M
|
$47.61 M
|
$45.78 M
|
$48.32 M
|
$39.14 M
|
$44.05 M
|
$262.00 K
|
$83.00 K
|
| Other Expenses |
$0.00
|
$10.00 M
|
$65.00 K
|
$75.00 K
|
$0.00
|
$5.83 M
|
$316.00 K
|
$0.00
|
$0.00
|
| Operating Expenses |
$174.62 M
|
$183.76 M
|
$218.59 M
|
$216.12 M
|
$206.31 M
|
$182.54 M
|
$99.33 M
|
$1.15 M
|
$83.00 K
|
| Cost And Expenses |
$174.62 M
|
$183.76 M
|
$218.59 M
|
$216.12 M
|
$210.58 M
|
$182.54 M
|
$99.33 M
|
$1.15 M
|
$83.00 K
|
| Interest Income |
$1.78 M
|
$2.00 M
|
$1.58 M
|
$761.00 K
|
$3.44 M
|
$0.00
|
$1.72 M
|
$0.00
|
$0.00
|
| Interest Expense |
$11.52 M
|
$13.51 M
|
$13.88 M
|
$19.44 M
|
$12.67 M
|
$0.00
|
$12.00 K
|
$118.00 K
|
$0.00
|
| Depreciation & Amortization |
$4.15 M
|
$4.39 M
|
$4.43 M
|
$5.17 M
|
$4.27 M
|
$3.09 M
|
$297.00 K
|
$1.15 M
|
$83.00 K
|
| EBITDA |
-$39.97 M |
-$161.92 M |
-$211.07 M |
-$209.40 M |
-$226.43 M |
-$179.45 M |
-$148.99 M |
-$6.65 M |
-$83.00 K |
| EBITDA Ratio |
-0.35
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Operating Income Ratio |
-0.52
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Total Other Income/Expenses Net |
$4.28 M
|
$3.94 M
|
-$10.79 M
|
-$17.88 M
|
-$32.78 M
|
$5.83 M
|
$2.02 M
|
-$118.00 K
|
$0.00
|
| Income Before Tax |
-$55.64 M
|
-$179.82 M
|
-$229.38 M
|
-$234.00 M
|
-$243.36 M
|
-$180.31 M
|
-$146.97 M
|
-$6.77 M
|
-$83.00 K
|
| Income Before Tax Ratio |
-0.49
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
$893.00 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Net Income |
-$56.53 M
|
-$179.82 M
|
-$229.38 M
|
-$234.00 M
|
-$243.36 M
|
-$180.82 M
|
-$146.97 M
|
-$6.77 M
|
-$83.00 K
|
| Net Income Ratio |
-0.49
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| EPS |
-0.25 |
-0.8 |
-2.84 |
-3.33 |
-3.67 |
-3.3 |
-2.43 |
-0.27 |
-0.0091 |
| EPS Diluted |
-0.25 |
-1.18 |
-2.84 |
-3.33 |
-3.67 |
-3.3 |
-2.43 |
-0.27 |
-0.0091 |
| Weighted Average Shares Out |
$226.23 M
|
$225.57 M
|
$84.57 M
|
$74.84 M
|
$68.51 M
|
$54.74 M
|
$60.40 M
|
$24.83 M
|
$9.16 M
|
| Weighted Average Shares Out Diluted |
$226.23 M
|
$225.57 M
|
$84.57 M
|
$74.84 M
|
$68.51 M
|
$54.74 M
|
$60.40 M
|
$24.83 M
|
$9.16 M
|
| Link |
|
|
|
|
|
|
|
|
|
